Cambridge Clinical Laboratories launches our new suite of tests to support the UK prostate cancer pathway.
Read MoreCambridge Clinical Laboratories (CCL) announces today, Friday 27 August, that CCL will be the UK partner for Prostatype Genomics in bringing the Prostatype® prostate cancer gene test to the UK market.
Read More